161 related articles for article (PubMed ID: 8865445)
1. Gastro-oesophageal reflux disease in The Netherlands. Results of a multicentre pH study.
Smout AJ; Geus WP; Mulder PG; Stockbrügger RW; Lamers CB
Scand J Gastroenterol Suppl; 1996; 218():10-5. PubMed ID: 8865445
[TBL] [Abstract][Full Text] [Related]
2. Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis.
Hatlebakk JG; Berstad A
Scand J Gastroenterol; 1996 Oct; 31(10):954-8. PubMed ID: 8898414
[TBL] [Abstract][Full Text] [Related]
3. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
van Zyl JH; de K Grundling H; van Rensburg CJ; Retief FJ; O'Keefe SJ; Theron I; Fischer R; Bethke T
Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):197-202. PubMed ID: 10741935
[TBL] [Abstract][Full Text] [Related]
5. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.
Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496
[TBL] [Abstract][Full Text] [Related]
6. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
McKenna CJ; Mills JG; Goodwin C; Wood JR
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
[TBL] [Abstract][Full Text] [Related]
7. Are frequent short gastro-oesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine?
Farup PG; Hovde O; Breder O
Scand J Gastroenterol; 1995 Sep; 30(9):829-32. PubMed ID: 8578179
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of cisapride and ranitidine at controlling oesophageal acid exposure in erosive oesophagitis.
Pouderoux P; Kahrilas PJ
Aliment Pharmacol Ther; 1995 Dec; 9(6):661-6. PubMed ID: 8824654
[TBL] [Abstract][Full Text] [Related]
9. Ranitidine versus cimetidine in the healing of erosive esophagitis.
McCarty-Dawson D; Sue SO; Morrill B; Murdock RH
Clin Ther; 1996; 18(6):1150-60. PubMed ID: 9001831
[TBL] [Abstract][Full Text] [Related]
10. Oral ranitidine and duration of gastric pH >4.0 in infants with persisting reflux symptoms.
Salvatore S; Hauser B; Salvatoni A; Vandenplas Y
Acta Paediatr; 2006 Feb; 95(2):176-81. PubMed ID: 16449023
[TBL] [Abstract][Full Text] [Related]
11. Daytime reduction of gastro-oesophageal reflux after healing of oesophagitis and its value as an indicator of favourable response to maintenance treatment.
Pace F; Sangaletti O; Bianchi Porro G
Gut; 1990 Sep; 31(9):1025-9. PubMed ID: 2210448
[TBL] [Abstract][Full Text] [Related]
12. Primary gastro-oesophageal reflux disease and irritable oesophagus syndrome as causes of recurrent abdominal pain in children.
Corrado G; Cavaliere M; Frandina G; Rea P; Pacchiarotti C; Capocaccia P; Cardi E
Ital J Gastroenterol; 1996; 28(8):462-9. PubMed ID: 9032590
[TBL] [Abstract][Full Text] [Related]
13. Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole--comparison of 24-hour intragastric and oesophageal pH.
Armbrecht U; Abucar A; Hameeteman W; Schneider A; Stockbrügger RW
Aliment Pharmacol Ther; 1997 Oct; 11(5):959-65. PubMed ID: 9354207
[TBL] [Abstract][Full Text] [Related]
14. Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte. Italian multicentre study.
Bovero E; Cheli R; Barbara L; Baldi F; Boero A; Mura GC; Camarri E; Corradini P; Dobrilla G; Piazzi L
Hepatogastroenterology; 1987 Aug; 34(4):155-9. PubMed ID: 3311954
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological management of gastro-oesophageal reflux disease.
Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
[TBL] [Abstract][Full Text] [Related]
16. Is ineffective oesophageal motility associated with reflux oesophagitis?
Fornari F; Callegari-Jacques SM; Scussel PJ; Madalosso LF; Barros EF; Barros SG
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):783-7. PubMed ID: 17700264
[TBL] [Abstract][Full Text] [Related]
17. The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis.
Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Aliment Pharmacol Ther; 1988 Jun; 2(3):221-7. PubMed ID: 2979246
[TBL] [Abstract][Full Text] [Related]
18. A dose-ranging study of ranitidine and its effect on intragastric and intra-oesophageal acidity in subjects with gastro-oesophageal reflux disease.
Thomson AB; Babiuk L; Kirdeikis P; Zuk L; Marriage B; Bowes K
Aliment Pharmacol Ther; 1994 Aug; 8(4):443-51. PubMed ID: 7986969
[TBL] [Abstract][Full Text] [Related]
19. The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy.
Peters FT; Kuipers EJ; Ganesh S; Sluiter WJ; Klinkenberg-Knol EC; Lamers CB; Kleibeuker JH
Aliment Pharmacol Ther; 1999 Jul; 13(7):921-6. PubMed ID: 10383527
[TBL] [Abstract][Full Text] [Related]
20. Cisapride in the treatment of gastro-oesophageal reflux disease.
Robertson CS; Evans DF; Ledingham SJ; Atkinson M
Aliment Pharmacol Ther; 1993 Apr; 7(2):181-90. PubMed ID: 8485271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
